- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Jagsonpal Pharmaceuticals Limited — Board Meeting, 21-01-2026: Outcome of Board Meeting
21-01-2026 | 05:10 pm
21-01-2026 | 05:10 pm
Jagsonpal Pharma's board approved the financial results for the quarter and nine months ended Dec 2025. Q3 revenue was ₹72.95 Cr, with profit after tax at ₹10.98 Cr. The company also noted a ₹2.08 Cr exceptional employee benefit expense.
No comments yet. Be the first to comment!